These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12967664)

  • 1. Antibody-dependent enhancement of infection: bacteria do it too.
    Mahalingam S; Lidbury BA
    Trends Immunol; 2003 Sep; 24(9):465-7. PubMed ID: 12967664
    [No Abstract]   [Full Text] [Related]  

  • 2. A hypothetical model for the development of invasive infection due to IgA1 protease-producing bacteria.
    Kilian M; Reinholdt J
    Adv Exp Med Biol; 1987; 216B():1261-9. PubMed ID: 3122532
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo cleavage of immunoglobulin A1 by immunoglobulin A1 proteases from Prevotella and Capnocytophaga species.
    Frandsen EV; Reinholdt J; Kjeldsen M; Kilian M
    Oral Microbiol Immunol; 1995 Oct; 10(5):291-6. PubMed ID: 8596672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.
    Fasching CE; Grossman T; Corthésy B; Plaut AG; Weiser JN; Janoff EN
    Infect Immun; 2007 Apr; 75(4):1801-10. PubMed ID: 17261616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract.
    Goldenberg HB; McCool TL; Weiser JN
    J Infect Dis; 2004 Oct; 190(7):1254-63. PubMed ID: 15346335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific proteolysis of human IgA by Streptococcus pneumoniae and Haemophilus influenzae.
    Mulks MH; Kornfeld SJ; Plaut AG
    J Infect Dis; 1980 Apr; 141(4):450-6. PubMed ID: 6989925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bacterial adherence by nasopharyngeal secretions.
    Kurono Y; Shimamura K; Shigemi H; Mogi G
    Ann Otol Rhinol Laryngol; 1991 Jun; 100(6):455-8. PubMed ID: 2058985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory immunity and the bacterial IgA proteases.
    Kornfeld SJ; Plaut AG
    Rev Infect Dis; 1981; 3(3):521-34. PubMed ID: 6792682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
    Nicoletti C
    Exp Mol Pathol; 1995 Apr; 62(2):99-108. PubMed ID: 8549700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local immunity and microbial IgA proteases].
    Chernokhvostova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):104-11. PubMed ID: 3307235
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of immune response to Streptococcus pneumoniae by administration of oral viridans streptococci via phosphorylcholine determinant.
    Miwa Y; Ito HO; Inoue M; Oho T
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):441-8. PubMed ID: 15708320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae.
    Briles DE; Claflin JL; Schroer K; Forman C
    Nature; 1981 Nov; 294(5836):88-90. PubMed ID: 6170000
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
    Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
    Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding studies with antibodies having phosphorylcholine specificity and fragments derived from their homologous Streptococcus pneumoniae type 27 capsular polysaccharide.
    Bennett LG; Glaudemans CP
    J Immunol; 1979 Jun; 122(6):2356-62. PubMed ID: 87460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera.
    Rodriguez ME; van der Pol WL; Sanders LA; van de Winkel JG
    J Infect Dis; 1999 Feb; 179(2):423-33. PubMed ID: 9878027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Antibody Orientation at the Bacterial Surface.
    Shannon O; Nordenfelt P
    Methods Mol Biol; 2017; 1535():331-337. PubMed ID: 27914090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of the oligomeric forms of MOPC 167 IgA with antigen and a circular dichroism study of the binding of pneumococcal C substance by monomer IgA.
    Young NM; Williams RE
    Mol Immunol; 1979 Mar; 16(3):145-52. PubMed ID: 39889
    [No Abstract]   [Full Text] [Related]  

  • 18. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Daniels CC; Briles TC; Mirza S; Håkansson AP; Briles DE
    Microb Pathog; 2006 May; 40(5):228-33. PubMed ID: 16540281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae.
    Nicoletti C; Yang X; Cerny J
    J Immunol; 1993 Jan; 150(2):543-9. PubMed ID: 8419487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.
    Mi QS; Zhou L; Schulze DH; Fischer RT; Lustig A; Rezanka LJ; Donovan DM; Longo DL; Kenny JJ
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6031-6. PubMed ID: 10811914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.